title: Comparative Effectiveness of Treatments for Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL), Using Matching Adjusted Indirect Comparison.
authors.affiliation: ICON Plc, Morristown, NJ, USA.
authors.forename: V
authors.initials: V
authors.lastname: Tongbram
authors.affiliation: Janssen Pharmaceuticals, Inc, Raritan, NJ, USA.
authors.forename: N
authors.initials: N
authors.lastname: Sengupta
authors.affiliation: Janssen Pharmaceuticals, Inc, Neuss, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Gaudig
authors.affiliation: ICON Plc, Morristown, NJ, USA.
authors.forename: M
authors.initials: M
authors.lastname: Sidhu
authors.affiliation: ICON plc, San Francisco, CA, USA.
authors.forename: A
authors.initials: A
authors.lastname: Exuzides
authors.affiliation: ICON plc, San Francisco, CA, USA.
authors.forename: C
authors.initials: C
authors.lastname: Colby
authors.affiliation: Janssen Pharmaceuticals, Inc., Beerse, Belgium.
authors.forename: S V
authors.initials: SV
authors.lastname: Sanden
authors.affiliation: ICON Plc, Morristown, NJ, USA.
authors.forename: A
authors.initials: A
authors.lastname: McGovern